Mia's Feed
Medical News & Research

Link Between Urinary Metal Levels and Increased Heart Failure Risk

Link Between Urinary Metal Levels and Increased Heart Failure Risk

Share this article

New research links elevated urinary metal levels to a higher risk of heart failure, highlighting the importance of reducing environmental metal exposure for cardiovascular health.

2 min read

Recent research conducted by Columbia University's Mailman School of Public Health has uncovered a significant association between exposure to specific metals, detected through urine analysis, and a higher likelihood of developing heart failure (HF). This large-scale, multi-cohort study is the most comprehensive to date, emphasizing the importance of monitoring environmental metal exposure as part of cardiovascular health strategies.

The study analyzed data from over 10,000 adults spanning diverse racial, ethnic, and geographic backgrounds, including cohorts from the United States and Spain. Researchers measured metal levels in urine samples—an indicator of body burden and elimination of metals—and collected extensive health and lifestyle data. Advanced machine learning models evaluated the combined effects of five urinary metals: arsenic, cadmium, molybdenum, selenium, and zinc.

The findings revealed that higher levels of these metals as a mixture correlated with an increased risk of heart failure: 55% in rural American Indian populations, 38% in urban and diverse American populations, and 8% in Spanish adults. When examined individually, doubling the urine concentrations of cadmium, a toxic metal common in tobacco, food, and industrial waste, was linked to a 15% higher risk of HF. Similarly, increased levels of molybdenum and zinc were associated with 13% and 22% higher risks, respectively. While essential for biological functions, excessive levels of zinc and selenium can be harmful.

The study highlights that exposure sources vary, including industrial activities, contaminated water, air pollution, smoking products, and certain foods. Notably, populations exposed to higher environmental contaminant levels—such as the studied cohorts—showed a consistent pattern of elevated HF risk. Researchers emphasize the urgent need for public health initiatives to reduce exposure, particularly among vulnerable communities.

Columbia experts, including lead author Irene Martinez-Morata and senior author Ana Navas-Acien, advocate for increased efforts to monitor and limit environmental metal exposure. Future investigations aim to understand the biological mechanisms linking metal toxicity to heart failure and explore environmental interventions for prevention. Overall, this study underscores the critical role environmental factors play in cardiovascular disease risk and the importance of minimizing harmful metal exposures.

For more details, see the original publication in JACC: Heart Failure: [DOI: 10.1016/j.jchf.2025.03.046]

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New COVID-19 Variant NB.1.8.1 Linked to Rising Cases Worldwide, WHO Reports

The WHO reports a new COVID-19 variant, NB.1.8.1, may be contributing to rising cases in parts of the world, though the overall health risk remains low. Vaccines are expected to continue offering protection.

New Biomarkers Identify Cardiovascular Risk in Type 2 Diabetes Patients

Research unveils epigenetic biomarkers that can predict cardiovascular disease risk in individuals with type 2 diabetes, paving the way for personalized preventive strategies.

NIH Sets Limit on Publishing Fees for Publicly Funded Research by 2026

NIH to implement a cap on publishing fees for research funded by the government starting in 2026, aiming to reduce costs and improve access to scientific findings.

Transforming Patient Education in Cardiac Rehabilitation: Building an Inclusive and Empowering Future

A visionary approach to patient education in cardiac rehabilitation emphasizes collaboration, personalization, and inclusivity to empower patients and improve outcomes.